Entity Common Stock, Shares Outstanding of Biostax Corp. from Q1 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biostax Corp. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q1 2013 to Q3 2024.
  • Biostax Corp. Entity Common Stock, Shares Outstanding for the quarter ending 19 Aug 2024 was 83.7M shares, a 0.14% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Biostax Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 83.7M +118K +0.14% 19 Aug 2024 10-Q 19 Aug 2024
Q2 2024 83.7M 04 Jun 2024 10-K/A 05 Jul 2024
Q1 2024 83.7M +443K +0.53% 15 Apr 2024 10-K 16 Apr 2024
Q3 2023 83.6M +12.5M +17.6% 18 Aug 2023 10-Q 18 Aug 2023
Q1 2023 83.3M +82.8M +17120% 31 Mar 2023 10-K 10 Apr 2023
Q3 2022 71.1M +70.6M +14650% 24 Aug 2022 10-Q 24 Aug 2022
Q1 2022 484K +1.81K +0.38% 18 Mar 2022 10-K 18 Mar 2022
Q4 2021 482K +17.4K +3.75% 15 Nov 2021 10-Q 12 Nov 2021
Q3 2021 482K +24.3K +5.32% 16 Aug 2021 10-Q 16 Aug 2021
Q2 2021 482K +24.3K +5.32% 24 May 2021 10-Q 24 May 2021
Q1 2021 482K +24.3K +5.32% 15 Apr 2021 10-K 15 Apr 2021
Q4 2020 464K +18.9K +4.24% 16 Nov 2020 10-Q 16 Nov 2020
Q3 2020 458K 24 Aug 2020 10-K/A 28 Aug 2020
Q2 2020 458K -445M -99.9% 29 Jun 2020 10-Q 30 Jun 2020
Q1 2020 458K -455M -99.9% 14 May 2020 10-K 14 May 2020
Q4 2019 446K 19 Nov 2019 10-Q 19 Nov 2019
Q2 2019 446M +36.6M +8.95% 08 Aug 2019 10-Q 14 Aug 2019
Q1 2019 456M +65.7M +16.9% 16 Apr 2019 10-K 16 Apr 2019
Q3 2018 434M +50.8M +13.2% 14 Nov 2018 10-Q 14 Nov 2018
Q2 2018 409M +73.4M +21.9% 12 Aug 2018 10-Q 14 Aug 2018
Q1 2018 390M +116M +42.5% 02 Apr 2018 10-K 02 Apr 2018
Q3 2017 384M +142M +59.1% 14 Nov 2017 10-Q 14 Nov 2017
Q2 2017 336M +115M +51.8% 14 Aug 2017 10-Q 14 Aug 2017
Q1 2017 274M +73.2M +36.5% 31 Mar 2017 10-K 31 Mar 2017
Q3 2016 241M 14 Nov 2016 10-Q 15 Nov 2016
Q2 2016 221M +71M +47.3% 12 Aug 2016 10-Q 15 Aug 2016
Q1 2016 200M +55.9M +38.7% 21 Mar 2016 10-K/A 16 May 2016
Q4 2015 178M 16 Nov 2015 10-Q/A 22 Dec 2015
Q2 2015 150M +49.7M +49.6% 12 Aug 2015 10-Q 14 Aug 2015
Q1 2015 145M +28M +24.1% 31 Mar 2015 10-K 31 Mar 2015
Q3 2014 133M +69.2M +109% 13 Nov 2014 10-Q 14 Nov 2014
Q2 2014 100M +41.4M +70.3% 12 Aug 2014 10-Q 14 Aug 2014
Q1 2014 117M +62.6M +116% 26 Mar 2014 10-K 31 Mar 2014
Q3 2013 63.7M 14 Nov 2013 10-Q 14 Nov 2013
Q2 2013 58.9M 12 Aug 2013 10-Q 13 Aug 2013
Q1 2013 53.9M 14 May 2013 10-Q 15 May 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.